Аптеки 36.6 logo
Аптеки 36.6 APTK

Аптеки 36.6 Financial Ratios 2004-2025 | APTK

Annual Financial Ratios Аптеки 36.6

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004

Price Earnings Ratio, P/E

395.89 -111.65 -96.4 -6.91 -0.53 -1.75 -1.26 -94.65 -120.89 -0.24 -4.18 -4.71 -6.12 -645.39 -139.19 -77.84 0.46 1.83 13.53

Price Sales Ratio, P/S

1.5 2.4 2.44 1.33 0.27 0.47 0.26 0.53 0.73 0.21 0.19 0.23 0.28 11.01 7.55 11.17 0.03 0.05 0.07

Price To Book Ratio, P/B

-13.73 -15.94 -16.77 -2.6 -0.33 -1.66 -22.26 12.15 -18.79 -0.23 18.94 4.08 2.63 106.58 883.68 124.55 0.18 0.31 0.37

Price Earnings To Growth Ratio, PEG

-3.18 5.58 1.05 0.08 -0.01 0.04 -0.0 -1.74 1.21 -0.0 0.69 -0.81 -0.0 8.24 3.14 0.77 0.0 0.0 -

Operating Cash Flow Per Share

0.86 0.42 -0.49 -0.36 -3.87 -4.22 -3.04 3.59 -0.33 -28.79 6.42 -0.01 -16.11 -0.49 0.08 -0.16 -131.41 -42.4 18.99

Free Cash Flow Per Share

0.73 0.29 -0.78 -0.76 -4.21 -4.4 -3.43 -0.71 -1.03 -29.55 -4.35 -7.12 -19.37 -0.53 -0.01 -0.36 -224.84 -103.37 -19.28

Cash Per Share

0.11 0.23 -0.06 0.17 0.21 0.25 0.51 0.27 0.36 3.88 6.65 9.28 8.53 0.15 0.14 0.17 37.73 24.97 5.09

Payout Ratio

- - - - - - - - - - - - - - - - - - -

Dividend Yield

- - - - - - - - - - - - - - - - - - -

Current Ratio

0.54 0.47 1.23 0.54 0.3 0.63 0.47 0.7 0.77 0.33 0.82 0.82 1.32 1.12 0.76 0.65 1.2 1.29 0.64

Quick Ratio

0.23 0.25 1.02 0.25 0.11 0.32 0.19 0.36 0.37 0.12 0.6 0.61 0.81 0.69 0.47 0.34 0.63 0.76 0.37

Cash Ratio

0.03 0.06 0.04 0.03 0.01 0.03 0.02 0.02 0.02 0.06 0.05 0.06 0.13 0.09 0.06 0.06 0.07 0.09 0.01

Days Of Sales Outstanding, DSO

- 40.61 - 17.97 12.5 30.36 16.44 18.34 111.85 10.33 123.51 144.6 - 81.41 57.09 - 75.39 75.13 65.04

Days Of Inventory Outstanding, DIO

80.59 80.2 74.31 83.65 66.59 76.28 78.0 71.14 255.17 69.75 92.84 100.8 122.2 98.83 60.24 106.22 115.66 98.3 82.31

Days Of Payables Outstanding, DPO

137.52 138.03 114.66 144.74 105.97 178.11 216.98 174.07 467.25 160.61 160.87 164.4 100.99 109.8 109.89 123.42 114.86 104.03 80.33

Operating Cycle

80.59 120.81 74.31 101.61 79.09 106.64 94.44 89.48 367.02 80.08 216.35 245.41 122.2 180.24 117.33 106.22 191.05 173.43 147.35

Cash Conversion Cycle

-56.93 -17.22 -40.35 -43.12 -26.88 -71.47 -122.54 -84.59 -100.23 -80.53 55.48 81.0 21.21 70.44 7.44 -17.19 76.19 69.4 67.03

Gross Profit Margin

0.34 0.34 0.35 0.28 0.13 0.22 0.21 0.28 0.29 0.25 0.36 0.45 0.41 0.39 0.34 0.3 0.35 0.39 0.38

Operating Profit Margin

0.08 0.01 0.02 -0.02 -0.09 -0.08 -0.11 -0.01 0.04 -0.66 0.11 0.08 0.06 0.04 -0.01 -0.07 0.02 0.05 0.05

Pretax Profit Margin

0.01 -0.03 -0.02 -0.19 -0.51 -0.27 -0.2 -0.04 -0.03 -0.83 0.05 -0.0 -0.0 0.01 -0.06 -0.12 0.1 0.04 0.02

Net Profit Margin

0.0 -0.02 -0.03 -0.19 -0.51 -0.27 -0.2 -0.01 -0.01 -0.87 -0.05 -0.05 -0.05 -0.02 -0.05 -0.14 0.07 0.03 0.01

Effective Tax Rate

0.46 -0.34 -0.54 -0.01 -0.01 0.0 0.01 0.13 0.66 -0.02 0.2 -11.52 -10.06 0.83 -0.22 -0.09 0.19 0.33 0.74

Return On Assets, ROA

0.01 -0.03 -0.02 -0.27 -0.7 -0.33 -0.21 -0.01 -0.0 -2.74 -0.04 -0.05 -0.05 -0.02 -0.1 -0.15 0.07 0.03 0.01

Return On Equity, ROE

-0.03 0.14 0.17 0.38 0.62 0.95 17.6 -0.13 0.16 0.97 -4.54 -0.87 -0.43 -0.17 -6.35 -1.6 0.4 0.17 0.03

Return On Capital Employed, ROCE

0.3 0.06 0.03 -0.13 1.0 -0.26 -0.31 -0.03 0.1 1.88 0.36 0.3 0.12 0.09 -0.07 -0.22 0.04 0.1 0.19

Net Income Per Ebt

0.54 0.66 1.54 1.01 1.01 1.0 0.99 0.13 0.2 1.05 -0.89 44.96 23.77 -2.32 0.94 1.2 0.67 0.61 0.28

Ebt Per Ebit

0.09 -2.86 -0.81 10.9 5.56 3.47 1.82 3.47 -0.69 1.27 0.47 -0.01 -0.03 0.18 4.39 1.79 4.12 0.9 0.35

Ebit Per Revenue

0.08 0.01 0.02 -0.02 -0.09 -0.08 -0.11 -0.01 0.04 -0.66 0.11 0.08 0.06 0.04 -0.01 -0.07 0.02 0.05 0.05

Debt Ratio

0.74 0.83 0.91 1.24 1.69 0.81 0.45 0.48 0.38 2.25 0.49 0.44 0.67 0.43 0.26 0.36 0.48 0.45 0.47

Debt Equity Ratio

-5.05 -4.71 -8.72 -1.72 -1.5 -2.33 -38.21 9.52 -16.83 -0.8 50.98 8.01 5.86 3.43 16.99 3.89 2.86 2.27 1.93

Long Term Debt To Capitalization

1.98 2.99 1.23 8.61 -2.92 1.95 1.03 0.9 1.11 -1.51 0.92 0.57 0.73 0.68 0.75 0.21 0.68 0.63 0.15

Total Debt To Capitalization

1.25 1.27 1.13 2.38 3.0 1.75 1.03 0.9 1.06 -4.01 0.98 0.89 0.85 0.77 0.94 0.8 0.74 0.69 0.66

Interest Coverage

1.13 - 0.17 -0.15 -0.64 -1.07 -2.06 -0.19 0.64 -5.28 1.58 1.24 1.0 0.75 -0.37 -1.47 0.74 1.0 1.41

Cash Flow To Debt Ratio

0.2 0.1 -0.07 -0.04 -0.17 -0.35 -0.17 0.29 -0.03 -0.42 0.07 -0.0 -0.15 -0.32 0.08 -0.11 -0.18 -0.12 0.08

Company Equity Multiplier

-6.78 -5.69 -9.54 -1.38 -0.89 -2.89 -84.3 19.69 -43.99 -0.36 103.93 18.3 8.7 7.93 65.92 10.69 5.95 5.06 4.09

Receivables Turnover

- 8.99 - 20.31 29.19 12.02 22.2 19.91 3.26 35.34 2.96 2.52 - 4.48 6.39 - 4.84 4.86 5.61

Payables Turnover

2.65 2.64 3.18 2.52 3.44 2.05 1.68 2.1 0.78 2.27 2.27 2.22 3.61 3.32 3.32 2.96 3.18 3.51 4.54

Inventory Turn Over

4.53 4.55 4.91 4.36 5.48 4.79 4.68 5.13 1.43 5.23 3.93 3.62 2.99 3.69 6.06 3.44 3.16 3.71 4.43

Fixed Asset Turnover

4.03 4.04 3.5 5.41 81.06 61.78 44.78 31.76 12.04 11.69 5.54 6.55 7.13 7.0 9.21 4.51 4.7 3.55 2.92

Asset Turnover

1.35 1.17 0.72 1.41 1.37 1.21 1.03 1.17 0.59 3.14 0.94 0.99 1.09 1.22 1.78 1.04 1.04 1.23 1.28

Operating Cash Flow Sales Ratio

0.11 0.07 -0.09 -0.04 -0.21 -0.23 -0.08 0.12 -0.02 -0.3 0.04 -0.0 -0.09 -0.11 0.01 -0.04 -0.08 -0.04 0.03

Free Cash Flow Operating Cash Flow Ratio

0.84 0.7 1.57 2.13 1.09 1.04 1.13 -0.2 3.16 1.03 -0.68 897 1.2 1.09 -0.09 2.22 1.71 2.44 -1.02

Cash Flow Coverage Ratios

0.2 0.1 -0.07 -0.04 -0.17 -0.35 -0.17 0.29 -0.03 -0.42 0.07 -0.0 -0.15 -0.32 0.08 -0.11 -0.18 -0.12 0.08

Short Term Coverage Ratios

1.11 0.28 -0.33 -0.27 -0.5 -2.92 -1.1 4.27 -0.08 -1.71 0.1 -0.0 -0.54 -0.85 0.11 -0.12 -0.68 -0.48 0.08

Capital Expenditure Coverage Ratio

6.37 3.29 -1.75 -0.88 -11.19 -24.26 -7.81 0.83 -0.46 -37.79 0.6 -0.0 -4.93 -11.37 0.92 -0.82 -1.41 -0.7 0.5

Dividend Paid And Capex Coverage Ratio

6.37 3.29 -1.75 -0.88 -11.19 -24.26 -7.81 0.83 -0.46 -37.79 0.6 -0.0 -4.93 -11.37 0.92 -0.82 -1.41 -0.7 0.5

Dividend Payout Ratio

- - - - - - - - - - - - - - - - - - -

Price To Free Cash Flows Ratio, P/FCF

15.88 47.22 -18.08 -16.09 -1.21 -1.98 -3.01 -22.31 -12.37 -0.66 -7.4 -5.43 -2.45 -89.7 -6873.68 -131.02 -0.21 -0.46 -2.46

Price To Operating Cash Flows Ratio, P/OCF

13.39 32.87 -28.41 -34.3 -1.31 -2.06 -3.39 4.43 -39.05 -0.68 5.01 -4874.35 -2.95 -97.58 612.64 -291.22 -0.36 -1.12 2.5

Price Cash Flow Ratio, P/CF

13.39 32.87 -28.41 -34.3 -1.31 -2.06 -3.39 4.43 -39.05 -0.68 5.01 -4874.35 -2.95 -97.58 612.64 -291.22 -0.36 -1.12 2.5

Enterprise Value Multiple, EV

11.49 63.69 14.84 82.7 -6.67 -7.34 -5.84 726.12 28.82 -1.29 4.74 6.8 9.96 131.88 496.41 -280.88 3.05 3.26 4.8

Price Fair Value, P/FV

-13.73 -15.94 -16.77 -2.6 -0.33 -1.66 -22.26 12.15 -18.79 -0.23 18.94 4.08 2.63 106.58 883.68 124.55 0.18 0.31 0.37

All numbers in RUB currency

Quarterly Financial Ratios Аптеки 36.6

2023-Q2 2022-Q4 2021-Q4 2021-Q2 2020-Q4 2020-Q2 2019-Q4 2019-Q2 2018-Q4 2018-Q2 2017-Q4 2017-Q2 2016-Q4 2016-Q2 2015-Q4 2015-Q2 2014-Q4 2014-Q2 2013-Q4 2013-Q2 2012-Q4 2012-Q2 2011-Q4 2010-Q4 2010-Q2 2009-Q4 2009-Q2 2008-Q4 2008-Q2 2007-Q4 2007-Q2 2006-Q4 2006-Q2 2005-Q4 2005-Q2

Price Earnings Ratio, P/E

296 - 77.8 -20.6 109 -10.3 -4.13 -2.36 -0.169 -0.625 -0.477 -2.14 -0.289 86.1 -8.82 12.9 - -0.936 -0.118 -0.135 53.3 - - -3.06 -3.06 -323 -323 -69.6 -69.6 -38.9 -38.9 0.229 0.229 0.915 0.915

Price Sales Ratio, P/S

3.38 - 4.56 5.1 8.39 3.69 3.34 1.7 0.537 0.609 0.792 0.937 0.466 0.501 0.976 0.827 - 0.14 0.412 0.471 0.887 - - 0.558 0.558 22 22 15.1 15.1 22.3 22.3 0.06 0.06 0.1 0.1

Price To Book Ratio, P/B

-15.5 - -15.9 -15.2 -18.8 -3.77 -3.57 -1.92 -0.322 -0.729 -1.47 817 -20.4 2.96 11.1 4.94 - -0.134 -0.237 -3.15 37.9 - - 2.63 2.62 107 190 884 218 125 111 0.185 0.231 0.309 0.338

Price Earnings To Growth Ratio, PEG

- - -0.601 0.033 -0.993 0.195 0.106 0.028 -0.001 0.013 -0.001 0.024 0.0 -0.802 0.033 - - 0.01 - 0.0 - - - - -0.0 - 4.12 - 1.61 - 0.387 - 0.001 - 0.001

Operating Cash Flow Per Share

0.0 - - -0.1 0.267 -0.79 0.282 -1.19 -1.53 -2.42 -2.03 -2.75 -1.93 -1.49 3.66 0.292 - -16.3 -33.1 4.27 1.52 - - -8.05 -8.05 -0.243 -0.243 0.039 0.039 -0.082 -0.082 -65.7 -65.7 -21.2 -21.2

Free Cash Flow Per Share

0.0 - - -0.144 0.219 -1.02 0.065 -1.36 -1.73 -2.49 -2.14 -2.79 -2.13 -1.66 3.47 0.292 - -16.4 -31.8 2.26 -1.0 - - -9.69 -9.69 -0.265 -0.265 -0.003 -0.003 -0.181 -0.181 -112 -112 -51.7 -51.7

Cash Per Share

0.068 - 0.226 0.239 -0.054 0.194 0.124 0.135 0.216 0.306 0.283 0.136 0.557 0.304 0.293 0.806 - 2.12 3.88 5.71 3.32 - - 8.53 7.34 0.151 0.148 0.145 0.155 0.165 0.118 37.7 31.4 25 15

Payout Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Dividend Yield

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

0.516 0.537 0.467 0.704 1.23 0.759 0.543 0.468 0.3 0.512 0.627 0.635 0.471 1.03 0.702 0.758 0.768 0.392 0.335 0.846 0.815 0.833 0.821 1.32 1.22 1.12 0.908 0.76 0.699 0.649 0.802 1.2 1.23 1.29 0.942

Quick Ratio

0.18 0.23 0.246 0.323 1.02 0.395 0.255 0.197 0.113 0.239 0.319 0.284 0.216 0.625 0.378 0.358 0.373 0.16 0.074 0.645 0.601 0.615 0.614 0.814 0.75 0.685 0.557 0.469 0.398 0.34 0.421 0.635 0.675 0.755 0.546

Cash Ratio

0.02 0.029 0.06 0.11 0.041 0.054 0.032 0.016 0.014 0.026 0.026 0.014 0.021 0.012 0.022 0.045 0.016 0.033 0.062 0.052 0.053 0.036 0.056 0.128 0.111 0.093 0.075 0.062 0.06 0.059 0.061 0.065 0.072 0.085 0.048

Days Of Sales Outstanding, DSO

- - 19 11.1 - 7.82 8.1 6.94 12.2 16 14.1 18.3 8.01 57.5 9.13 11.6 - 0.651 1.16 65.7 - - -0.061 - 20.7 40.1 40.6 28.2 14.1 - 12.9 37.2 29.7 37.1 29.8

Days Of Inventory Outstanding, DIO

38.4 - 37.6 37.5 48.1 33.3 32.9 36.8 37.9 39.1 34.6 43.9 33.9 56.7 32.1 53.2 - 17.7 41.8 56.3 51.8 50.6 95.9 60.3 56.1 48.7 47.8 29.7 33.8 52.4 44.6 57 42.2 48.5 38.5

Days Of Payables Outstanding, DPO

58.1 - 62.5 50 74.2 37.3 60 53.8 62 65.2 81.7 87.8 103 126 82.7 102 - 34.7 89.4 121 89.7 97.5 156 49.8 53.8 54.1 69.9 54.2 49.1 60.9 48.7 56.6 42.8 51.3 39.6

Operating Cycle

38.4 - 56.6 48.6 48.1 41.2 41 43.8 50.1 55.1 48.8 62.2 41.9 114 41.2 64.8 - 18.3 42.9 122 51.8 50.6 95.8 60.3 76.8 88.9 88.4 57.9 47.9 52.4 57.4 94.2 71.9 85.5 68.2

Cash Conversion Cycle

-19.7 - -5.92 -1.42 -26.1 3.86 -19 -10.1 -11.8 -10.2 -32.9 -25.6 -60.9 -11.4 -41.5 -36.8 - -16.4 -46.4 1.15 -37.9 -46.9 -60.6 10.5 23.1 34.7 18.6 3.67 -1.23 -8.48 8.75 37.6 29.1 34.2 28.7

Gross Profit Margin

0.331 - 0.341 0.337 0.233 0.21 0.18 0.164 0.258 0.234 0.213 0.295 0.19 0.275 0.241 0.327 - 0.263 0.251 0.251 0.354 0.422 0.476 0.412 0.412 0.394 0.394 0.344 0.344 0.298 0.298 0.347 0.347 0.386 0.386

Operating Profit Margin

0.174 - -0.115 0.152 0.034 0.029 -0.011 -0.042 -0.105 -0.076 -0.139 -0.044 -0.243 0.029 -0.093 0.067 - -0.014 -0.655 -0.655 -0.002 0.072 0.139 0.062 0.062 0.042 0.042 -0.013 -0.013 -0.067 -0.067 0.024 0.024 0.049 0.049

Pretax Profit Margin

0.005 - -0.008 -0.06 0.117 -0.081 -0.199 -0.179 -0.782 -0.243 -0.417 -0.109 -0.401 -0.003 -0.106 0.022 - -0.038 -0.83 -0.83 -0.092 0.027 0.061 -0.002 -0.002 0.007 0.007 -0.058 -0.058 -0.12 -0.12 0.098 0.098 0.045 0.045

Net Profit Margin

0.003 - 0.015 -0.062 0.019 -0.09 -0.202 -0.18 -0.792 -0.244 -0.415 -0.109 -0.403 0.001 -0.028 0.016 - -0.037 -0.873 -0.873 0.004 -0.038 -0.082 -0.046 -0.046 -0.017 -0.017 -0.054 -0.054 -0.144 -0.144 0.065 0.065 0.027 0.027

Effective Tax Rate

0.453 - -2.46 -0.028 0.072 -0.113 -0.017 -0.007 -0.012 -0.003 -0.006 -0.008 -0.005 -1.46 -0.017 0.406 - -0.007 -0.017 -0.017 -0.165 0.986 0.265 -10.1 -10.1 0.835 0.835 -0.215 -0.215 -0.092 -0.092 0.19 0.19 0.332 0.332

Return On Assets, ROA

0.002 - 0.009 -0.037 0.005 -0.067 -0.156 -0.113 -0.534 -0.148 -0.266 -0.055 -0.21 0.001 -0.016 0.009 - -0.114 -1.24 -0.234 0.002 -0.018 -0.022 -0.025 -0.026 -0.01 -0.01 -0.048 -0.045 -0.075 -0.088 0.034 0.045 0.017 0.02

Return On Equity, ROE

-0.013 - -0.051 0.185 -0.043 0.092 0.216 0.204 0.474 0.292 0.768 -95.4 17.7 0.009 -0.315 0.096 - 0.036 0.502 5.84 0.178 -0.796 -0.403 -0.215 -0.214 -0.083 -0.147 -3.17 -0.784 -0.8 -0.711 0.202 0.252 0.084 0.092

Return On Capital Employed, ROCE

0.316 - -0.299 0.164 0.015 0.053 -0.041 -0.124 0.568 -0.173 -0.241 -0.044 -0.334 0.034 -0.104 0.085 - 0.046 1.04 -0.467 -0.003 0.128 0.136 0.058 0.063 0.047 0.058 -0.034 -0.033 -0.112 -0.094 0.02 0.026 0.049 0.071

Net Income Per Ebt

0.547 - -1.83 1.03 0.165 1.11 1.02 1.01 1.01 1 0.994 1.01 1.01 -0.458 0.26 0.74 - 0.988 1.05 1.05 -0.045 -1.42 -1.34 23.8 23.8 -2.32 -2.32 0.941 0.941 1.2 1.2 0.668 0.668 0.61 0.61

Ebt Per Ebit

0.03 - 0.07 -0.395 3.42 -2.79 18.9 4.26 7.46 3.21 2.99 2.47 1.65 -0.11 1.15 0.324 - 2.73 1.27 1.27 46.6 0.369 0.439 -0.031 -0.031 0.176 0.176 4.39 4.39 1.79 1.79 4.12 4.12 0.902 0.902

Ebit Per Revenue

0.174 - -0.115 0.152 0.034 0.029 -0.011 -0.042 -0.105 -0.076 -0.139 -0.044 -0.243 0.029 -0.093 0.067 - -0.014 -0.655 -0.655 -0.002 0.072 0.139 0.062 0.062 0.042 0.042 -0.013 -0.013 -0.067 -0.067 0.024 0.024 0.049 0.049

Debt Ratio

0.776 0.744 0.828 0.906 0.913 1.41 1.24 1.16 1.69 1.06 0.806 0.589 0.453 0.352 0.484 0.365 0.383 2.76 2.03 0.546 0.491 0.437 0.438 0.674 0.558 0.433 0.345 0.258 0.314 0.364 0.412 0.482 0.471 0.449 0.458

Debt Equity Ratio

-4.99 -5.05 -4.71 -4.46 -8.72 -1.95 -1.72 -2.1 -1.5 -2.1 -2.33 1.02 K -38.2 4.13 9.52 3.88 -16.8 -0.868 -0.826 -13.7 51 18.9 8.01 5.86 4.64 3.43 4.89 17 5.51 3.89 3.32 2.86 2.64 2.27 2.12

Long Term Debt To Capitalization

2.05 1.98 2.99 1.48 1.23 3.42 8.61 8.71 -2.92 2.96 1.95 0.999 1.03 0.798 0.899 0.767 1.11 -2.39 -1.63 1.2 0.922 0.801 0.567 0.727 0.706 0.68 0.69 0.75 0.379 0.214 0.564 0.679 0.662 0.629 0.501

Total Debt To Capitalization

1.25 1.25 1.27 1.29 1.13 2.06 2.38 1.91 3 1.91 1.75 0.999 1.03 0.805 0.905 0.795 1.06 -6.58 -4.73 1.08 0.981 0.95 0.889 0.854 0.823 0.774 0.83 0.944 0.846 0.795 0.768 0.741 0.725 0.694 0.679

Interest Coverage

- - - - 0.209 0.305 -0.094 -0.343 - - - - - - - - - - -5.28 -5.28 - 1.03 - 1.0 1.0 0.75 0.75 -0.374 -0.374 -1.47 -1.47 0.743 0.743 0.996 0.996

Cash Flow To Debt Ratio

0.0 - - -0.024 0.041 -0.107 0.048 -0.096 -0.064 -0.142 -0.147 -0.242 -0.1 -0.092 0.268 0.025 - -0.177 -0.487 0.044 0.035 0.043 0.174 -0.076 -0.096 -0.159 -0.199 0.042 0.032 -0.055 -0.057 -0.089 -0.121 -0.061 -0.071

Company Equity Multiplier

-6.43 -6.78 -5.69 -4.92 -9.54 -1.38 -1.38 -1.81 -0.889 -1.98 -2.89 1.73 K -84.3 11.7 19.7 10.7 -44 -0.314 -0.407 -25 104 43.2 18.3 8.7 8.31 7.93 14.2 65.9 17.5 10.7 8.06 5.95 5.61 5.06 4.62

Receivables Turnover

- - 4.74 8.11 - 11.5 11.1 13 7.37 5.64 6.37 4.92 11.2 1.57 9.86 7.73 - 138 77.3 1.37 - - -1.48 K - 4.34 2.24 2.22 3.2 6.39 - 6.99 2.42 3.03 2.43 3.02

Payables Turnover

1.55 - 1.44 1.8 1.21 2.41 1.5 1.67 1.45 1.38 1.1 1.03 0.875 0.717 1.09 0.886 - 2.59 1.01 0.744 1 0.923 0.576 1.81 1.67 1.66 1.29 1.66 1.83 1.48 1.85 1.59 2.1 1.75 2.28

Inventory Turn Over

2.34 - 2.39 2.4 1.87 2.7 2.74 2.44 2.37 2.3 2.6 2.05 2.65 1.59 2.81 1.69 - 5.09 2.16 1.6 1.74 1.78 0.939 1.49 1.6 1.85 1.88 3.03 2.66 1.72 2.02 1.58 2.13 1.86 2.34

Fixed Asset Turnover

1.98 - 2.13 1.88 1.14 2.8 2.96 2.22 2.22 28 33.1 23.4 22.7 19.5 15.7 12 - 13.9 6.18 1.24 2.42 3.2 1.79 3.56 3.47 3.5 3.32 4.6 3.87 2.25 2.71 2.35 2.62 1.78 1.92

Asset Turnover

0.714 - 0.615 0.605 0.235 0.74 0.772 0.624 0.674 0.605 0.641 0.504 0.519 0.504 0.578 0.56 - 3.06 1.41 0.268 0.411 0.488 0.27 0.543 0.565 0.61 0.609 0.888 0.825 0.521 0.615 0.52 0.689 0.614 0.734

Operating Cash Flow Sales Ratio

0.0 - - -0.036 0.159 -0.204 0.077 -0.178 -0.161 -0.249 -0.185 -0.283 -0.087 -0.064 0.224 0.016 - -0.16 -0.7 0.09 0.042 0.039 0.282 -0.095 -0.095 -0.113 -0.113 0.012 0.012 -0.038 -0.038 -0.083 -0.083 -0.044 -0.044

Free Cash Flow Operating Cash Flow Ratio

0.724 - - 1.44 0.82 1.29 0.231 1.14 1.13 1.03 1.06 1.02 1.11 1.11 0.95 1 - 1.01 0.962 0.53 -0.66 -0.693 0.72 1.2 1.2 1.09 1.09 -0.089 -0.089 2.22 2.22 1.71 1.71 2.44 2.44

Cash Flow Coverage Ratios

0.0 - - -0.024 0.041 -0.107 0.048 -0.096 -0.064 -0.142 -0.147 -0.242 -0.1 -0.092 0.268 0.025 - -0.177 -0.487 0.044 0.035 0.043 0.174 -0.076 -0.096 -0.159 -0.199 0.042 0.032 -0.055 -0.057 -0.089 -0.121 -0.061 -0.071

Short Term Coverage Ratios

0.0 - - -6.39 0.201 -0.829 0.297 -0.396 -0.193 -0.504 -1.24 -1.61 -0.641 -2.17 3.97 0.167 - -0.945 -1.96 0.079 0.046 0.055 0.198 -0.27 -0.302 -0.423 -0.371 0.053 0.037 -0.06 -0.095 -0.34 -0.467 -0.24 -0.136

Capital Expenditure Coverage Ratio

3.62 - - -2.26 5.55 -3.47 1.3 -6.93 -7.51 -33 -17.9 -63.5 -9.48 -8.71 19.9 - - -100 -26.5 2.13 0.603 0.591 3.58 -4.93 -4.93 -11.4 -11.4 0.918 0.918 -0.818 -0.818 -1.41 -1.41 -0.695 -0.695

Dividend Paid And Capex Coverage Ratio

3.62 - - -2.26 5.55 -3.47 1.3 -6.93 -7.51 -33 -17.9 -63.5 -9.48 -8.71 19.9 - - -100 -26.5 2.13 0.603 0.591 3.58 -4.93 -4.93 -11.4 -11.4 0.918 0.918 -0.818 -0.818 -1.41 -1.41 -0.695 -0.695

Dividend Payout Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Price To Free Cash Flows Ratio, P/FCF

99.9 K - - -96.9 64.2 -14.1 189 -8.35 -2.93 -2.37 -4.06 -3.26 -4.83 -7.01 4.58 50.4 - -0.866 -0.612 9.84 -32.2 - - -4.9 -4.9 -179 -179 -13.7 K -13.7 K -262 -262 -0.422 -0.422 -0.919 -0.919

Price To Operating Cash Flows Ratio, P/OCF

72.3 K - - -140 52.7 -18.1 43.6 -9.56 -3.32 -2.44 -4.29 -3.31 -5.34 -7.82 4.35 50.4 - -0.875 -0.589 5.21 21.2 - - -5.9 -5.9 -195 -195 1.23 K 1.23 K -582 -582 -0.723 -0.723 -2.24 -2.24

Price Cash Flow Ratio, P/CF

72.3 K - - -140 52.7 -18.1 43.6 -9.56 -3.32 -2.44 -4.29 -3.31 -5.34 -7.82 4.35 50.4 - -0.875 -0.589 5.21 21.2 - - -5.9 -5.9 -195 -195 1.23 K 1.23 K -582 -582 -0.723 -0.723 -2.24 -2.24

Enterprise Value Multiple, EV

40.9 - 140 117 53.2 45.7 708 32.1 -37.4 -47.5 -18.7 -145 -6.26 29.5 -22.1 17.6 - -149 -2.57 -3.48 104 7.23 9.33 19.9 17.1 264 262 993 998 -562 -562 6.1 4.57 6.51 5.79

Price Fair Value, P/FV

-15.5 - -15.9 -15.2 -18.8 -3.77 -3.57 -1.92 -0.322 -0.729 -1.47 817 -20.4 2.96 11.1 4.94 - -0.134 -0.237 -3.15 37.9 - - 2.63 2.62 107 190 884 218 125 111 0.185 0.231 0.309 0.338

All numbers in RUB currency

Multiples are an important financial analysis tool for the company Аптеки 36.6, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Pharmaceutical retailers industry

Issuer Price % 24h Market Cap Country
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.
CJJD
- -5.59 % $ 49.9 M chinaChina
Greenlane Holdings Greenlane Holdings
GNLN
$ 3.09 3.17 % $ 23.3 M usaUSA
BOQI International Medical BOQI International Medical
BIMI
- 6.33 % $ 5.86 M chinaChina
Trxade Group Trxade Group
MEDS
- 4.55 % $ 5.8 M usaUSA
PetMed Express PetMed Express
PETS
$ 3.01 0.88 % $ 62 M usaUSA
LifeMD LifeMD
LFMD
$ 3.43 -1.01 % $ 116 M usaUSA
Rite Aid Corporation Rite Aid Corporation
RAD
- - $ 35.5 M usaUSA
111 111
YI
$ 3.6 -3.74 % $ 619 M chinaChina
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
- - $ 10.3 B usaUSA